![Logo for Novacyt S.A.](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F5b843-2024-07-17-10-50-53.png&w=256&q=100)
Novacyt Investor Relations Material
Latest events
![Logo for Novacyt S.A.](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F5b843-2024-07-17-10-50-53.png&w=128&q=100)
H2 2023
Novacyt
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Novacyt S.A.
Access all reports
Novacyt S.A. is a biotechnology company focused on the development, manufacturing, and commercialization of clinical diagnostic products. It operates primarily through its business units, including Primerdesign, Lab21 Products, and IT-IS International. The company specializes in in vitro and molecular diagnostics, offering a wide range of assays, reagents, and PCR devices for detecting various infectious diseases, including pathogens responsible for respiratory, gastrointestinal, and insect-borne illnesses. Novacyt serves a global market, providing its products to public hospitals, central laboratories, and private testing facilities. The company is headquartered in Camberley, United Kingdom, and its shares are listed on the Euronext Growth.
Key slides for Novacyt S.A.
![Our combined strengt](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fnovacyt-sa-h1-2023--9f4b75835420af61%2F15.png&w=3840&q=75)
![Logo for Novacyt S.A.](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F5b843-2024-07-17-10-50-53.png&w=128&q=100)
H1 2023
Novacyt S.A.
![Trading update : Jan](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fnovacyt-sa-h2-2023-30330ba3009ec81f%2F9.png&w=3840&q=75)
![Logo for Novacyt S.A.](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F5b843-2024-07-17-10-50-53.png&w=128&q=100)
H2 2023
Novacyt S.A.
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
ALNOV
Country
🇫🇷 France